You are here

Public Cord Blood Banking

Public cord blood banking supports the health of the community. Public banks collect qualifying cord blood donations from healthy pregnancies and save them in case one of them will be the match to save the life of a patient who needs a stem cell transplant. In the United States our registry of donors is called Be The Match. Patients who have a rare genetic type are more likely to receive cord blood transplants. In order for parents to donate cord blood to a public bank, their baby must be born at a hospital that accepts donations. Public cord blood banking is highly recommended by both the American Academy of Pediatrics (AAP) and American Medical Association (AMA).

Public     Be The Match Public     Public & Family    


22, Wheatcrofts Rd, Seetha Nagar, Nungambakkam, Tamil Nadu 600034, India, Chennai

Jeevan (also known as is the first purely public cord blood bank set up in India, funded by a tie-up with the state of Tamil Nadu, that enables quick and affordable (free for the poor) access to matching stem cells from donated umbilical cord blood for the life-saving treatment of Indians with blood cancers, thalassaemia, and other blood disorders.


Dhirubhai Ambani Life Sciences Center.Thane-Belapur Road, Navi Mumbai

Reliance Life Sciences Pvt. Ltd. established the first cord blood repository in South East Asia and has always offered both public donation and family storage.  Reliance Life Sciences is active in medical, plant and industrial biotechnology.  They are a part of the Reliance Group of companies, a member of the Fortune Global 500.

School of Tropical Medicine

108, Chittaranjan Avenue, Kolkata, West Bengal 700073, India

The School of Tropical Medicine (STM) in Kolkata has launched the first public cord blood bank in India that is funded by the government.

StemCyte India

Apollo Hospital Campus, Bhat GIDC Estate,ahmedabad Rd,., Gandhinagar

StemCyte India is the only cord blood bank in India having a ‘hybrid+ ‘ model that combines Private Banking, Public Banking, Advanced Therapeutics and Clinical trials. StemCyte India is a joint venture between StemCyte Inc., Apollo Hospital Enterprises Ltd., and Cadila Pharmaceuticals Ltd. StemCyte India began operations in 2010, and has delivered 43 cord blood therapies to date. In late 2016 StemCyte became the first cord blood bank in India to be accredited by FACT, and their CEO Mr Deepak Chhabra is now on the board of the international Cord Blood Association.